Clyde Markowitz: What is NEDA and How Does it Help Patient Care

Video

As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.

As new treatments are developed for multiple sclerosis one of the questions has become how do you measure their success. A possible metric being developed is No Evidence of Disease Activity or NEDA.

Speaking at the annual meeting of the Consortium of Multiple Sclerosis Centers Clyde Markowitz, MD, from the University of Pennsylvania said that not only are there questions about what NEDA means but also which model of it provides the best and most definitive results to help guide a patient's care.

Related Videos
Elizabeth Cerceo, MD | Credit: ACP
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
© 2024 MJH Life Sciences

All rights reserved.